Corporate Magazine 2012 - Boehringer Ingelheim

usiness year 2012our companyOUR COMPANYBoehringer Ingelheim is a research-driven company dedicated toresear ching and developing, manufacturing and marketing pharmaceuticalsthat help to improve health and quality of life.Our businesses are human pharmaceuticals and veterinary medicines.We focus on innovative drugs and treatments that represent therapeuticadvances.Excellence in innovation and technology guides our actions in allareas. Our products have long been highly successful in the treatmentof respiratory, cardiovascular, central nervous system and infectiousdisorders. We have successfully launched new and innovative productsin thrombo-embolic and metabolic diseases. In addition, we have successfullyadvanced our research in respiratory, infectious and oncologicaldiseases.We have more than 46,000 employees in 140 affiliated companies andoperate global networks of research and development (R&D) facilitiesat six sites and 20 production sites in 13 countries. R&D expenditurein the business area Prescription Medicines corresponds to 22.5% of itsnet sales.Our headquarters is at Ingelheim, the German town where the familyownedcompany was founded in 1885.Our Company5